
Mosquito Bites Might Not Be Random. Find Out What Makes You a Target
If you're like me, you get frustrated by the number of mosquito bites you acquire. It's downright infuriating when I come inside sporting several new welts, especially when my friends report that they don't have a single one. Why is that?
I did some research and found that it's not because I'm particularly unlucky. There are actually scientific reasons why mosquitoes single out certain people. Here's why mosquitoes bite and how you can make yourself less of a target this summer.
For more, learn about how to safely remove a tick and how you can alter the colors of your hydrangeas.
Why do mosquitoes bite?
Contrary to what you might think, mosquitoes don't bite people for food; they feed on plant nectar. Only female mosquitoes bite, and they do so to receive proteins from your blood needed to develop their eggs.
Why are some people more prone to bites?
There are several factors that impact why some people are more prone to mosquito bites than others:
Blood type
A common belief is that mosquitoes are attracted to certain blood types, considering mosquitoes bite humans for their blood. Blood type is determined by genetics, and each blood type is created based on the different sets of specific proteins, called antigens, on the surface of red blood cells. There are four main blood types: A, B, AB and O.
While there are no firm conclusions as to which blood type is more attractive to mosquitoes, several studies have suggested people with type O are most appetizing to mosquitoes. A 2019 study observed mosquito feeding behavior when presented with different blood type samples, and found mosquitoes fed from the type O feeder more than any other. A 2004 study also found that mosquitoes land on blood group O secretors (83.3%) significantly more than group A secretors (46.5%).
However, these studies are not definitive, and much is still up in the air about mosquito preferences when it comes to blood type.
Clothing color
Mosquitoes are highly visual hunters when it comes to finding a human to bite. This means movement and dark clothing colors like black, navy and red can stand out to a mosquito. Research has shown that mosquitoes are more attracted to the color black, but there has been little additional research into why this is the case.
Carbon dioxide
Mosquitoes use sight and smell to find hosts to bite. One of the quickest ways mosquitoes can sniff out a person is through the carbon dioxide emitted when we breathe. According to research published in the journal Chemical Senses, mosquitoes use an organ called a maxillary palp for carbon dioxide detection and can sense it from 164 feet away.
Because carbon dioxide is a huge attractor, people who emit more of it -- larger individuals and people who are breathing heavily when working out -- are more attractive to a mosquito.
Body odor and sweat
Mosquitoes are attracted to more substances and compounds than just carbon dioxide. Mosquitoes can find people to bite by smelling substances present on human skin and in sweat, including lactic acid, uric acid and ammonia.
A new study found that mosquitoes are attracted to compounds called carboxylic acids that every human produces through sebum, a waxy coating, on their skin. The sebum is eaten by the millions of beneficial microorganisms found on human skin, which produces more carboxylic acid -- and will, in turn, produce an odor similar to cheese or smelly feet that appears to attract mosquitoes. Lead researchers on this study said mosquitoes are sensitive to human odor and that even perfumes or colognes can't mask it.
Researchers are still learning why certain body odors are more attractive to mosquitoes, but they do know that genetics, bacteria on the skin and exercise all play a factor. Genetics impact the amount of uric acid emitted, while exercise increases lactic acid buildup.
Beer
In a small study, mosquitoes were observed to land on participants more frequently after consuming a small amount of beer. But before you swear off outdoor brews, know that the study only had 14 participants, and it found that mosquitoes may only be marginally more attracted to people who have been drinking beer.
The size and severity of a bite relate to how your immune system responds to the saliva introduced by the mosquito when it bites.
Suriyawut Suriya/EyeEm/Getty Images
Why do some people swell from mosquito bites more than others?
Mosquito bites can range in size from small little spots to large welts. Why is this the case?
Bites affect people differently. The size and severity of a bite relate to how your immune system responds to the saliva introduced by the mosquito when it bites. When mosquitoes bite, they inject some saliva when drawing blood. This saliva contains certain anticoagulants and proteins, triggering the immune system to respond to these foreign substances.
Our body responds by releasing histamine -- a chemical released by white blood cells when your immune system is fighting allergens -- which causes the itchiness and inflammation of the bite.
How to prevent mosquito bites
The best way to handle a mosquito bite is to not get them in the first place -- but oftentimes, that's easier said than done.
Some common ways to prevent mosquito bites include:
Use repellents and bug sprays
Use natural repellants (citronella essential oil
Avoid going outside at dawn or dusk
Avoid dark-colored clothing, specifically black
Avoid standing water and try to eliminate standing water near your home
Use mosquito netting when camping or sleeping outdoors
Wear long sleeves and pants
Prevent mosquito bites when traveling internationally
If you're using DEET insect repellent, make sure to follow the Centers for Disease Control and Prevention's guidelines (PDF) about the strength and proper application.
Repellants are highly effective in preventing mosquito bites.
Amanda Capritto/CNET
How to treat mosquito bites
Mosquito bites, while annoying, are often not severe and will resolve in a few days. In the meantime, there are several treatments to alleviate the itchiness and inflammation:
Clean with rubbing alcohol if a fresh bite
Take an oatmeal bath
Use over-the-counter antihistamines such as Benadryl or Claritin
Apply mild corticosteroid creams
Use aloe vera to reduce inflammation
Try a cold compress or ice pack for 10 minutes
Though difficult, try as best you can to not itch the bite too roughly to prevent any sort of skin reaction or infection.
Mosquito-borne diseases and illnesses
While the majority of mosquito bites result in welts that heal in a few days, mosquitoes are known carriers of many deadly diseases and illnesses, including but not limited to:
Mosquitoes are often considered one of the deadliest animals on earth. Mosquito-borne diseases kill more than 725,000 people a year the World Health Organization estimates, with malaria accounting for the vast majority of deaths (600,000).
While malaria and other mosquito-borne diseases hit Sub-Saharan Africa the hardest, mosquitoes pose a risk to every continent and nation. Most types of mosquitoes in the US are nuisance mosquitoes -- mosquitoes that do not spread germs that make people sick -- but there have been outbreaks of West Nile, dengue, chikungunya and Zika in a few states and territories.
There are several steps you can take to control mosquito populations and minimize risk. Make sure to properly cover and store water containers around your home and drain any standing water to prevent mosquitoes from laying eggs. For treatments, you can use an outdoor adulticide to kill adult mosquitoes or larvicides to treat bodies of standing water that will not be used for drinking and cannot be drained.
Infected bites will often look extremely red, swollen and warm or have a red streak that spreads outward from the bite. See a health care provider if you have signs of infection or if symptoms worsen.
For more, read about the five smart ways to repel mosquitoes this summer, the mosquito forecast tool launched by Google and Off, and how you can make your own DIY traps for mosquitoes, hornets and other flying pests.
More tips for your yard and garden

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock experienced a volatile trading session on Monday, after the company announced positive topline results from its Phase 2 RADIANT study evaluating vormatrigine in patients with focal onset seizures and generalized epilepsy. The stock initially surged on the news, but then reversed course and is currently trading down approximately 9%. The central nervous system (CNS) disorders-focused company said the topline results from the Phase 2 RADIANT study included data from 37 patients.'These findings build on our earlier clinical data showing a differentiated profile for vormatrigine as a fast-acting, no-titration, once-daily oral drug with no requirement to be taken with food, and a favorable DDI profile, all of which are unseen in ASMs currently in the market or in development,' said Marcio Souza, president and CEO of Praxis. In an investor presentation on the company website, Praxis noted that the trial showed a median seizure reduction of around 56.3%, with 60% of the patients achieving at least a 50% reduction in seizures. This positive outcome has encouraged the company to move forward with a Phase 2/3 trial, even though 23% of patients discontinued the study. 54% of patients achieved at least a 50% seizure reduction threshold in Week 1 and 67% in Week 8. In the last month of the dataset, 22% of the patients experienced a 100% reduction in seizure frequency. The company added that most adverse events were mild to moderate and transient. All severe and serious adverse events (AEs) were recovered and resolved. The investor presentation noted that the investigators had the option to reduce the dose of the background medication to manage AEs; when done (6 patients), no discontinuation was observed. The company said it is on track to complete the pivotal, 12-week POWER1 study in the fourth quarter of 2025 and, based on the results from RADIANT, it expects to initiate the POWER2 study shortly. On Monday, the company reported cash and investments of approximately $447 million and maintains a cash runway into 2028. In July, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for Praxis Precision's relutrigine, a sodium channel functional state modulator for pediatric use for SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs). The EMBOLD cohort 2 pivotal trial is on track for topline results in the first half of 2026, with NDA filing to follow. Praxis has recently initiated the EMERALD study investigating relutrigine broadly in DEEs. Price Action: PRAX stock is trading lower by 9.51% to $48.95 at last check Monday. Read Next:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.


Medscape
12 minutes ago
- Medscape
Ethics of Artificial Hydration and Nutrition In Dementia
This transcript has been edited for clarity. Hi. I'm Art Caplan. I'm at the Division of Medical Ethics at the NYU Grossman School of Medicine. I had a difficult case brought to me recently by someone who was trying to decide what to do with a patient with very bad dementia in terms of feeding. It's not the first time I've had this kind of case brought to me by physicians, and it probably won't be the last, but it remains a thorny, tough ethics quandary. I think everybody understands that there is a right — and we've had this affirmed since cases like Terri Schiavo or Nancy Cruzan — to not force artificial feeding (meaning by tube, in the nose, or in the stomach) or artificial hydration upon someone who doesn't want it. If you have the right to refuse treatment, it's been established — certainly in American law, and I would say by standards of care within the medical profession — that hydration and feeding, when they're done by mechanical means, tubes, or using artificial substances to supply nutrition, are medicine. As a medical intervention or a medical therapy, just like other interventions, such as dialysis or even refusing an amputation for a diabetic patient, the patient ultimately, if they're competent, has the right to refuse it. The challenge comes in the case that was presented to me. A woman, let's call her Mary Taylor, some years ago knew that she was at risk of getting Alzheimer's disease. She filled out her living will and discussed with her family that when she became demented, if she was unable to care for herself, if she couldn't recognize her family and friends, she did not want any medical interventions, including specifically hydration and nutrition. Sadly, she went through the course of declining and ended up at a nursing home. At the nursing home, the doctor who was treating her noticed that nurses were offering Mary food on a spoon and liquid on a spoon, that she was opening her mouth when the spoon was presented, and she was, if you will, eating and drinking. The physician, knowing that the family remembered this advance directive living will and knowing that they were the designated decision-makers, basically said stop the spoon-feeding. The nurses did not want to do it. They said it's ordinary care. It's not medical. It's just what you do as part of what one human being deserves from another human being — to offer them ordinary ways to drink water or to eat something. The case basically raises two tough ethics questions. Is feeding by spoon the same as medical intervention with artificial forms of hydration and nutrition? I believe it is. I believe that when you say 'no more food and nutrition,' it isn't just the equipment. I'll put it simply: It's who's on the end of the spoon. If nurses or doctors are feeding, it's medical. It's professional care, and you should be able to say no to that. Secondly, I do think if someone says 'I don't want to eat or drink anymore,' their intent and their values are clear. You could certainly rediscuss it with the family and say she seems to be accepting food and swallowing, and ask if that changes their mind or makes them think she might have decided differently. However, I think the wishes of the competent person, when they made the living will, are what should drive care if the person loses competency. They thought about it, they knew where they were headed, and I do think that's the value that ought to dominate thinking about whether we have to continue to try food and water for nutrition. Does that mean that you can't offer ice, lip balm, or other comfort means if someone is suffering because they're getting dehydrated and so on? Absolutely not. That isn't the same as feeding them. Here are some lessons to consider. It's important to pay attention when someone says they don't want food and water. Are nurses or anyone in a hospital or a nursing home trying to feed them anyway because they don't think of spoon-feeding as an artificial or medical intervention? I think they need education about that, and I think it's important to make sure that does not happen if that's what they said in their advance directives. I also believe advance directives and conversations with people, when they're competent or facing the potential loss of competency, should include discussions about whether they really mean everything, such as spoon-feeding or somebody offering you a glass of water. Is that included in what you are saying you do not want? We have to be thorough and comprehensive in making sure that we're clear so there really aren't disputes of what people did say no to and might say yes to if they no longer are able to tell us directly. I'm Art Caplan, at the Division of Medical Ethics at the NYU Grossman School of Medicine. Thank you for watching.


Medscape
12 minutes ago
- Medscape
Three FDA-Approved Obesity Drugs That Aren't GLP-1s
This transcript has been edited for clarity. There are currently three FDA-approved oral medications for the long-term treatment of obesity that are not GLP-1 based. Alli or Xenical (generic name orlistat) was approved by the FDA in 1999. It works by inhibiting intestinal lipase and it reduces absorption of dietary fat by up to 30%. Common side effects are gastrointestinal and include fatty or oily stool, fecal urgency, and incontinence. The average placebo-subtracted weight loss is about 3.8%. Alli is the only FDA-approved medication available over the counter. Qsymia is a combination of phentermine and topiramate and was approved by the FDA in 2012. Phentermine is a sympathomimetic, and topiramate is a neurostabilizer that enhances GABA activity. Clinically, the combination pill enhances satiety, decreases appetite, and reduces binge eating behaviors. Common side effects are paresthesias, altered taste, tachycardia, irritability, hypertension, insomnia, and dry mouth. It is currently one of the most effective oral medications, with an average placebo-subtracted weight loss of 8.6%. Contrave is a combination pill of bupropion and naltrexone and was approved by the FDA in 2014. Bupropion is a norepinephrine and dopamine reuptake inhibitor, and naltrexone is a mu opioid receptor antagonist. Clinically, it decreases appetite and cravings. The common side effects are nausea, vomiting, insomnia, constipation, dry mouth, diarrhea, and dizziness. The average placebo-subtracted weight loss is 4.8%.